Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Stock DD Board Message Board

Insmed Inc (INSM) 13.32 $INSM DEADLINE APPROACH

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 273331
Posted On: 09/03/2016 5:05:49 AM
Avatar
Posted By: Stock_Tracker
Insmed Inc (INSM) 13.32 $INSM

DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Sep 02, 9:58AM CDT
LOS ANGELES, CA / ACCESSWIRE / September 2, 2016 / Lundin Law PC (the "Firm" announces class action lawsuit has been filed against Insmed Incorporated ("Insmed" or the "Company" (Nasdaq: INSM) concerning possible violations of federal securities laws between March 18, 2013 and June 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action Against Insmed Incorporated (INSM) & Lead Plaintiff Deadline - September 13, 2016
GlobeNewswire - Fri Sep 02, 9:00AM CDT
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of New Jersey on behalf of those who purchased shares of Insmed Incorporated ("Insmed" or the "Company" (NASDAQ:INSM) and certain of its officers, during the period between March 18, 2013 and June 8, 2016, inclusive (the "Class Period".
INSM: 13.32 (-0.07)

INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Insmed Incorporated of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 13, 2016
BusinessWire - Fri Sep 02, 8:51AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
INSM: 13.32 (-0.07)

APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Sep 01, 12:39PM CDT
IRVINE, CA / ACCESSWIRE / September 1, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Insmed Incorporated ("Insmed" or the "Company" (Nasdaq: INSM). Investors, who purchased or otherwise acquired shares between March 18, 2013 and June 8, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Insmed Incorporated Of Upcoming Deadline
GlobeNewswire - Thu Sep 01, 11:18AM CDT
Rigrodsky & Long, P.A.:
INSM: 13.32 (-0.07)

Insmed Announces Upcoming Presentations at European Respiratory Society 2016 International Congress
GlobeNewswire - Wed Aug 31, 7:00AM CDT
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported that three INS1009-related abstracts were accepted for presentation at the European Respiratory Society (ERS) 2016 International Congress taking place in London from September 3rd to 7th. INS1009 is a nebulized treprostinil prodrug, which may offer a differentiated product profile with therapeutic potential in rare pulmonary disorders such as pulmonary arterial hypertension, idiopathic pulmonary fibrosis, sarcoidosis, and severe refractory asthma.
INSM: 13.32 (-0.07)

SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 29, 11:30AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 29, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Insmed Incorporated ("Insmed" or the "Company" (Nasdaq: INSM) concerning possible violations of federal securities laws between March 18, 2013 and June 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

INSM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016
BusinessWire - Mon Aug 29, 9:13AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Insmed Incorporated (NASDAQ: INSM) securities between March 18, 2013 and June 8, 2016.
INSM: 13.32 (-0.07)

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Insmed Incorporated of Class Action Lawsuit and Upcoming Deadline - INSM
GlobeNewswire - Sun Aug 28, 6:00PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Insmed Incorporated ("Insmed" or the "Company" (NASDAQ:INSM) and certain of its officers. The class action, filed in United States District Court District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Insmed securities between March 18, 2013 and June 8, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
INSM: 13.32 (-0.07)

SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 24, 6:49PM CDT
IRVINE, CA / ACCESSWIRE / August 24, 2016 / Khang & Khang LLP (the "Firm" announces a class action lawsuit has been filed against Insmed Incorporated ("Insmed" or the "Company" (NASDAQ: INSM). Investors, who purchased or otherwise acquired shares between March 18, 2013 and June 8, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

INSM INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016
PR Newswire - Wed Aug 24, 8:52AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Insmed Incorporated (NASDAQ: INSM) securities between March 18, 2013 and June 8, 2016.
INSM: 13.32 (-0.07)

EQUITY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Aug 19, 10:25AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 19, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Insmed Incorporated ("Insmed" or the "Company" (Nasdaq: INSM) concerning possible violations of federal securities laws between March 18, 2013 and June 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

INVESTOR NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Aug 15, 2:45PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 15, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Insmed Incorporated ("Insmed" or the "Company" (Nasdaq: INSM) concerning possible violations of federal securities laws between March 18, 2013 and June 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

INSM SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016
BusinessWire - Mon Aug 15, 9:48AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Insmed Incorporated (NASDAQ: INSM) securities between March 18, 2013 and June 8, 2016.
INSM: 13.32 (-0.07)

SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Aug 12, 12:32PM CDT
IRVINE, CA / ACCESSWIRE / August 12, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Insmed Incorporated ("Insmed" or the "Company" (NASDAQ: INSM). Investors, who purchased or otherwise acquired shares between March 18, 2013 and June 8, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Aug 11, 1:18PM CDT
LOS ANGELES, CA / ACCESSWIRE / August 11, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Insmed Incorporated ("Insmed" or the "Company" (NASDAQ: INSM) concerning possible violations of federal securities laws between March 18, 2013 and June 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Shareholders of Class Action against Insmed Incorporated (INSM) and Lead Plaintiff Deadline: September 13, 2016
ACCESSWIRE - Thu Aug 11, 9:21AM CDT
NEW YORK, NY / ACCESSWIRE / August 11, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of New Jersey on behalf of those who purchased shares of Insmed Incorporated ("Insmed" or the "Company" (NASDAQ: INSM) and certain of its officers, during the period between March 18, 2013 and June 8, 2016, inclusive (the "Class Period".
INSM: 13.32 (-0.07)

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Encourages Investors with Losses to Contact the Firm
ACCESSWIRE - Wed Aug 10, 11:30AM CDT
LOS ANGELES, CA / ACCESSWIRE / August 10, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Insmed Incorporated ("Insmed" or the "Company" (NASDAQ: INSM) concerning possible violations of federal securities laws between March 18, 2013 and June 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the September 13, 2016 lead plaintiff motion deadline.
INSM: 13.32 (-0.07)

INSM INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Insmed Incorporated and a Lead Plaintiff Deadline of September 13, 2016
GlobeNewswire - Wed Aug 10, 10:24AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Insmed Incorporated (NASDAQ:INSM) securities between March 18, 2013 and June 8, 2016.
INSM: 13.32 (-0.07)



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us